Pharma and social media: an uneasy marriage?
Despite being the fastest growing marketing medium for many industries, social media channels present major legal and regulatory concerns for the pharma sector. Until the FDA produces some guidance later this year, companies wanting to enter the social media fray have much to think about, explains Tim Worden.
Lawyers Tim Worden
This article was written by Tim Worden and featured in the 11 May 2010 edition of SCRIP News and is reprinted with the kind permission of the editors.
